<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McFarland JM</submitter><funding>Howard Hughes Medical Institute</funding><funding>NCI NIH HHS</funding><pagination>4296</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7453022</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Assays to study cancer cell responses to pharmacologic or genetic perturbations are typically restricted to using simple phenotypic readouts such as proliferation rate. Information-rich assays, such as gene-expression profiling, have generally not permitted efficient profiling of a given perturbation across multiple cellular contexts. Here, we develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation responses across a mixture of samples with single-cell resolution, using SNP-based computational demultiplexing of single-cell RNA-sequencing data. We show that MIX-Seq can be used to profile responses to chemical or genetic perturbations across pools of 100 or more cancer cell lines. We combine it with Cell Hashing to further multiplex additional experimental co</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action.</pubmed_title><pmcid>PMC7453022</pmcid><funding_grant_id>U01 CA250549</funding_grant_id><funding_grant_id>K08 CA218420</funding_grant_id><funding_grant_id>P50 CA127003</funding_grant_id><funding_grant_id>U01 CA224146</funding_grant_id><pubmed_authors>Shibue T</pubmed_authors><pubmed_authors>Kuksenko O</pubmed_authors><pubmed_authors>Tsherniak A</pubmed_authors><pubmed_authors>Rozenblatt-Rosen O</pubmed_authors><pubmed_authors>Chambers E</pubmed_authors><pubmed_authors>Jones A</pubmed_authors><pubmed_authors>Paolella BR</pubmed_authors><pubmed_authors>Bender S</pubmed_authors><pubmed_authors>Geiger-Schuller K</pubmed_authors><pubmed_authors>Rothberg M</pubmed_authors><pubmed_authors>Wolpin BM</pubmed_authors><pubmed_authors>Warren A</pubmed_authors><pubmed_authors>Regev A</pubmed_authors><pubmed_authors>Vazquez F</pubmed_authors><pubmed_authors>Dionne D</pubmed_authors><pubmed_authors>Colgan WN</pubmed_authors><pubmed_authors>Tirosh I</pubmed_authors><pubmed_authors>McFarland JM</pubmed_authors><pubmed_authors>Roth JA</pubmed_authors><pubmed_authors>Golub TR</pubmed_authors><pubmed_authors>Aguirre AJ</pubmed_authors><pubmed_authors>Ghandi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action.</name><description>Assays to study cancer cell responses to pharmacologic or genetic perturbations are typically restricted to using simple phenotypic readouts such as proliferation rate. Information-rich assays, such as gene-expression profiling, have generally not permitted efficient profiling of a given perturbation across multiple cellular contexts. Here, we develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation responses across a mixture of samples with single-cell resolution, using SNP-based computational demultiplexing of single-cell RNA-sequencing data. We show that MIX-Seq can be used to profile responses to chemical or genetic perturbations across pools of 100 or more cancer cell lines. We combine it with Cell Hashing to further multiplex additional experimental co</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2026-05-02T20:07:17.956Z</modification><creation>2025-05-18T12:17:46.507Z</creation></dates><accession>S-EPMC7453022</accession><cross_references><pubmed>32855387</pubmed><doi>10.1038/s41467-020-17440-w</doi></cross_references></HashMap>